Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fentanyl citrate 400mcg lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Fentanyl 400 microgram buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Fentanyl 100 microgram buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 600 microgram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Fentanyl 300 microgram buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 200 microgram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Product containing precisely fentanyl 800 microgram/1 each conventional release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fentanyl citrate |
Inferred relationship |
Some |
|
Product containing precisely fentanyl (as fentanyl citrate) 100 microgram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl (as fentanyl citrate) 500 microgram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 50 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 100 microgram buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl (as fentanyl citrate) 200 microgram/1 each conventional release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Product containing precisely fentanyl (as fentanyl citrate) 400 microgram/1 each conventional release buccal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 600 microgram buccal tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 200 microgram oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 400 microgram oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |
Fentanyl (as fentanyl citrate) 600 microgram oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fentanyl citrate |
Inferred relationship |
Some |
1 |